Actively Recruiting
Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
Led by AstraZeneca · Updated on 2026-02-24
400
Participants Needed
18
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A multicentre observational study on treatment patterns and ctDNA HRR evaluation in aggressive high-volume metastatic hormone-sensitive prostate cancer in Russian Federation
CONDITIONS
Official Title
Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients aged 6 18 years old
- Signed informed consent form including consent for blood samples for ctDNA and HRRm testing
- Diagnosis of metastatic hormone-sensitive prostate cancer (de novo or progressed from earlier stages)
- High-aggressive disease with Gleason score 8-10
- High-volume disease with 4 or more bone metastases (including at least one outside vertebral column/pelvis) and/or 1 or more visceral metastasis
- Availability of source medical documentation
- Known HRRm status based on tumor sample evaluation performed in routine practice
You will not qualify if you...
- Participation in any interventional trial since metastatic prostate cancer diagnosis
- Progression to metastatic castration-resistant prostate cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 18 locations
1
Research Site
Arkhangelsk, Russia
Actively Recruiting
2
Research Site
Barnaul, Russia
Actively Recruiting
3
Research Site
Chelyabinsk, Russia
Actively Recruiting
4
Research Site
Irkutsk, Russia
Not Yet Recruiting
5
Research Site
Krasnodar, Russia
Not Yet Recruiting
6
Research Site
Krasnoyarsk, Russia
Not Yet Recruiting
7
Research Site
Moscow, Russia
Not Yet Recruiting
8
Research Site
Moscow, Russia
Actively Recruiting
9
Research Site
Nal'chik, Russia
Not Yet Recruiting
10
Research Site
Nizhny Novgorod, Russia
Not Yet Recruiting
11
Research Site
Obninsk, Russia
Actively Recruiting
12
Research Site
Omsk, Russia
Not Yet Recruiting
13
Research Site
Saint Petersburg, Russia
Not Yet Recruiting
14
Research Site
Saransk, Russia
Not Yet Recruiting
15
Research Site
Tomsk, Russia
Not Yet Recruiting
16
Research Site
Tyumen, Russia
Actively Recruiting
17
Research Site
Ufa, Russia
Actively Recruiting
18
Research Site
Yekaterinburg, Russia
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here